Patients are encouraged to consult with their healthcare provider if symptoms persist or worsen
Under these guidelines, the default BUD for a sterile compounded preparation stored under refrigeration is relatively conservative unless the pharmacy has conducted extended stability testing on their specific formulation
Research , such as oral semaglutide weight loss trials , indicates that higher doses of semaglutide (25 mg or semaglutide 50 mg ) yield significant HbA1c reduction
If you feel your concerns are not being adequately addressed, you have the right to request a second opinion or referral to a specialist diabetes service
SURMOUNT-5 Trial Overview SURMOUNT-5 (NCT05822830) is a multicenter, randomized, open-label Phase 3b trial aimed at assessing the efficacy and safety of Zepbound (tirzepatide) compared to Wegovy (semaglutide) in adults with obesity or overweight, with at least one comorbidity (such as hypertension, dyslipidemia, obstructive sleep apnea (OSA), or cardiovascular disease), and no diabetes